New Issue of European Endocrinology Vol 13 Iss 2 Published and Distributed at EASD, Lisbon

Monday, October 23, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, October 23, 2017 /PRNewswire/ --

European Endocrinology, led by Editor-in-Chief Dr Abd

Tahrani, Birmingham, UK, was distributed to touchENDOCRINOLOGY's database, plus to attendees of the European Association for the Study of Diabetes annual meeting in Lisbon, Portugal,
11-15 September 2017.

     (Logo: http://mma.prnewswire.com/media/515766/Touch_Medical_Logo.jpg )

The new peer-reviewed issue featured expert content on a range of salient topics including a supplement on 20 years of DPP-4 inhibition in Type 2 Diabetes, another discussing CGM uptake in the UK, and a range of other topics from CV Risk, Diabetic Macular Oedema, Diabetes Pathogenesis and the link between Diabetes and Hyperthyroidism. The full edition can be accessed here, via open access: http://www.touchendocrinology.com/journals/editions/european-endocrinology-volume-13-issue-2-autumn-2017

A number of expert interviews were also filmed, which are presented on touchENDOCRINOLOGY.com via open access: http://www.touchendocrinology.com/video-categories/easd-highlights

A selection of articles includes:

Ten Years of Vildagliptin 

Stefano Del Prato https://doi.org/10.17925/EE.2017.13.02.54

The Vildagliptin Experience - 25 Years Since the Initiation of the Novartis Glucagon-like Peptide-1 Based Therapy Programme and 10 Years Since the First Vildagliptin Registration 

James E Foley, Bo Ahrén https://doi.org/10.17925/EE.2017.13.02.56

Dipeptidyl Peptidase-4 Inhibitor Development and Post-authorisation Programme for Vildagliptin - Clinical Evidence for Optimised Management of Chronic Diseases Beyond Type 2 Diabetes 

William David Strain, Päivi M Paldánius https://doi.org/10.17925/EE.2017.13.02.62

Clinical Safety and Tolerability of Vildagliptin - Insights from Randomised Trials, Observational Studies and Post-marketing Surveillance 

Chantal Mathieu, Plamen Kozlovski, Päivi M Paldánius, James E Foley, Vikas Modgill, Marc Evans, Carmen Serban https://doi.org/10.17925/EE.2017.13.02.68

Continuous Glucose Monitoring Adoption in the United Kingdom - An Economic and Policy Perspective 

Nick Oliver https://doi.org/10.17925/EE.2017.13.02.73

Is Continuous Glucose Monitoring Underappreciated in the UK? 

Christopher G Parkin, Melissa Holloway, Jeffrey Truesdell, Tomas Walker https://doi.org/10.17925/EE.2017.13.02.76

An Economic Evaluation of Continuous Glucose Monitoring for People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia within North West London Clinical Commissioning Groups in England 

Shraddha Chaugule, Nick Oliver, Brigitte Klinkenbijl, Claudia Graham https://doi.org/10.17925/EE.2017.13.02.81

touchENDOCRINOLOGY (a division of Touch Medical Media) publishesEuropean Endocrinology, a peer-reviewed, open access, bi-annual journal specialising in the publication of balanced and comprehensive review articles written by leading authorities to address the most important and salient developments in the field of endocrinology. The aim of these reviews is to break down the high science from 'data-rich' primary papers and provide practical advice and opinion on how this information can help physicians in the day to day clinical setting. Practice guidelines, symposium write-ups, case reports, and original research articles are also featured to promote discussion and learning amongst physicians, clinicians, researchers and related healthcare professionals.

www.touchENDOCRINOLOGY.com

"Touch Medical Media is a trading name of Touch Digital Media Limited, a private limited company registered in England and Wales at The White House Mill Road, Goring, Reading, England, RG8 9DD with registered number 08197142".

For inquires please contact: Nicola Cartridge - Editorial Director [email protected]

"Leading the Debate on the Advances in Healthcare"

SOURCE touchENDOCRINOLOGY



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store